Todd C. Brady

2019

In 2019, Todd C. Brady earned a total compensation of $4.1M as President and Chief Executive Officer at Aldeyra Therapeutics, a 44% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$235,350
Option Awards$1,359,210
Salary$523,000
Stock Awards$2,012,500
Other$11,201
Total$4,141,261

Brady received $2M in stock awards, accounting for 49% of the total pay in 2019.

Brady also received $235.4K in non-equity incentive plan, $1.4M in option awards, $523K in salary and $11.2K in other compensation.

Rankings

In 2019, Todd C. Brady's compensation ranked 2,861st out of 13,971 executives tracked by ExecPay. In other words, Brady earned more than 79.5% of executives.

ClassificationRankingPercentile
All
2,861
out of 13,971
80th
Division
Manufacturing
1,036
out of 5,701
82nd
Major group
Chemicals And Allied Products
344
out of 2,200
84th
Industry group
Drugs
281
out of 1,886
85th
Industry
Pharmaceutical Preparations
207
out of 1,398
85th
Source: SEC filing on April 27, 2020.

Brady's colleagues

We found two more compensation records of executives who worked with Todd C. Brady at Aldeyra Therapeutics in 2019.

2019

Joshua Reed

Aldeyra Therapeutics

Chief Financial Officer

2019

David Clark

Aldeyra Therapeutics

Chief Medical Officer

News

You may also like